effect overlay
activetrials
Dementia
Dementia
EP004 - Anavex OLE

Open Label Extension Study for Patients with Early Alzheimer’s Disease (AD) Enrolled in Study ANAVEX2-73-AD-004
 

HREC: 2020.257
Principal Investigator: Prof Amy Brodtmann
Coordinator contact: Sophie Robinson
Funding: Commercial
Dementia
Dementia
SELENATE 002

A Phase 2b Randomised Controlled Trial of Sodium Selenate as a Disease Modifying Treatment for Probably Behavioural Variant Fronto-temporal Dementia
 

HREC: 2020.171
Principal Investigator: Prof Dennis Velakoulis
Coordinator contact: Lauren Martell
Funding: Non-Commercial
Dementia
Dementia
SLT for Vascular Dementia

A Multicentre, Randomised, Double-Blind, Placebo Controlled Trial to Evaluate the Effectiveness and Safety of Sailuotong (SLT), a Standardised Herbal Medicine Formula in Patients with Vascular Dementia and Alzheimer's Disease with Cerebrovascular Disease
 

HREC: 2018.225
Principal Investigator: A/Prof Nawaf Yassi
Coordinator contact: Sophie Robinson
Funding: Non-Commercial
Dementia
Dementia
3D

Deferiprone to Delay Dementia (The 3D Study): a clinical proof of cencept study
 

HREC: 2017.172
Principal Investigator: Dr Christopher Kyndt
Coordinator contact: Lauren Martell
Funding: Commercial
Placeholder
Brain Tumour/Neurosurgery
Brain cancer survivorship - Phase 2

Responding to need: technology-enhanced brain cancer survivorship – Phase 2
 

HREC: 2022.264
Principal Investigator: Prof Kate Drummond
Coordinator contact: Dr Verena Schadewaldt
Funding: Non-Commercial